Bin Zhao

8PUBLICATIONS
2CO-AUTHORS
Molecular targetsPredictive and prognostic markersImmunogenetics (incl. genetic immunology)Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 24, 2026
Aging is associated with the outcomes of immune checkpoint blockade in renal cell carcinoma.

|Feb 25, 2026
M2 macrophages promote lymphatic metastasis by regulating PKM2 nuclear translocation in triple-negative breast cancer.

Yuqin Yang, Honghui Ye, Di Zhong

|Mar 16, 2024
Sex disparities revealed by single-cell and bulk sequencing and their impacts on the efficacy of immunotherapy in esophageal cancer.

Huimeng Yan, Jinyuan Huang, Yingying Li

|Jun 15, 2021
Pan-cancer analysis of SETD2 mutation and its association with the efficacy of immunotherapy.

Mingdong Lu, Bin Zhao, Mengshan Liu

|Jul 31, 2020
Efficacy of PD-1/PD-L1 blockade monotherapy in clinical trials.

Bin Zhao, Hong Zhao, Jiaxin Zhao

|Feb 22, 2020
Fatal adverse events associated with programmed cell death protein 1 or programmed cell death-ligand 1 monotherapy in cancer.

Bin Zhao, Hong Zhao, Jiaxin Zhao

Pageof 2

Frequent Collaborators

1 joint publications

Wenjing Tian

1 joint publications

Hong Zhao